|
1
|
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.
|
Clin Cancer Res
|
2009
|
7.35
|
|
2
|
Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.
|
J Clin Oncol
|
2009
|
5.70
|
|
3
|
Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma.
|
J Clin Oncol
|
2003
|
2.36
|
|
4
|
Facts and indicators on palliative care development in 52 countries of the WHO European region: results of an EAPC Task Force.
|
Palliat Med
|
2007
|
2.30
|
|
5
|
Hypoxia, notch signalling, and prostate cancer.
|
Nat Rev Urol
|
2013
|
2.24
|
|
6
|
Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
|
J Clin Oncol
|
2006
|
1.56
|
|
7
|
Funding for palliative care programs in developing countries.
|
J Pain Symptom Manage
|
2007
|
1.51
|
|
8
|
Hospice and palliative care development in Africa: a multi-method review of services and experiences.
|
J Pain Symptom Manage
|
2007
|
1.37
|
|
9
|
Mapping levels of palliative care development: a global view.
|
J Pain Symptom Manage
|
2008
|
1.34
|
|
10
|
Perceptions of women medical students and their influence on career choice.
|
Am J Surg
|
2002
|
1.17
|
|
11
|
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.
|
Proc Natl Acad Sci U S A
|
2002
|
1.12
|
|
12
|
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer.
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.10
|
|
13
|
A decade of advances in treatment for advanced non-small cell lung cancer.
|
Clin Chest Med
|
2011
|
1.03
|
|
14
|
Noncoding RNAs in prostate cancer: the long and the short of it.
|
Clin Cancer Res
|
2013
|
0.95
|
|
15
|
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors.
|
Cancer
|
2006
|
0.95
|
|
16
|
Adjuvant treatment of lung cancer: current status and potential applications of new regimens.
|
Lung Cancer
|
2004
|
0.87
|
|
17
|
Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
|
Int J Radiat Oncol Biol Phys
|
2004
|
0.85
|
|
18
|
Gene expression and epigenetic discovery screen reveal methylation of SFRP2 in prostate cancer.
|
Int J Cancer
|
2012
|
0.84
|
|
19
|
Official certification of doctors working in palliative medicine in Europe: data from an EAPC study in 52 European countries.
|
Palliat Med
|
2007
|
0.82
|
|
20
|
Examining the inventory of interpersonal problems as a tool for conducting analogue studies of mechanisms underlying Borderline Personality Disorder.
|
J Behav Ther Exp Psychiatry
|
2004
|
0.81
|
|
21
|
Manipulating the epigenome for the treatment of urological malignancies.
|
Pharmacol Ther
|
2013
|
0.81
|
|
22
|
IGFBP7 promoter methylation and gene expression analysis in prostate cancer.
|
J Urol
|
2012
|
0.81
|
|
23
|
A phase I clinical trial of sequentially administered doxorubicin and topotecan in refractory solid tumors.
|
Clin Cancer Res
|
2002
|
0.80
|
|
24
|
Lost in translation: integrating medical interpreters into the multidisciplinary team.
|
Oncologist
|
2008
|
0.80
|
|
25
|
Consensus building on access to controlled medicines: a four-stage Delphi consensus procedure.
|
J Pain Symptom Manage
|
2013
|
0.79
|
|
26
|
Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.79
|
|
27
|
Second line chemotherapy for NSCLC: establishing a gold standard.
|
Lung Cancer
|
2002
|
0.79
|
|
28
|
Carotid intima media thickness decreases after pancreas transplantation.
|
Transplantation
|
2002
|
0.78
|
|
29
|
In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer.
|
Prostate
|
2011
|
0.78
|
|
30
|
Bariatric surgery using a network and teleconferencing to serve remote patients in the Veterans Administration Health Care System: feasibility and results.
|
Am J Surg
|
2011
|
0.77
|
|
31
|
Guidelines for the use of PET-CT in children.
|
Nucl Med Commun
|
2008
|
0.75
|
|
32
|
Point of view.
|
Spine (Phila Pa 1976)
|
2002
|
0.75
|
|
33
|
Racism in the chemotherapy infusion unit: a nurse's story.
|
Oncologist
|
2008
|
0.75
|
|
34
|
The talking cure: Schwartz Center Rounds foster compassion and collaboration.
|
J Cancer Educ
|
2008
|
0.75
|